Published in Dig Dis Sci on August 01, 1995
Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases. J Gastroenterol (2016) 0.92
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging (2003) 0.89
Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease. Dig Dis Sci (2001) 0.83
How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol (2016) 0.81
Are we giving biologics too much time? When should we stop treatment? World J Gastroenterol (2008) 0.79
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut (2001) 4.23
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet (1996) 3.15
Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther (2012) 2.74
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
Genetic analyses of chromosome 12 loci in Crohn's disease. Gut (2000) 2.30
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol (1998) 2.20
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
Effect of a 2 g cimetidine infusion on twenty-four-hour intragastric pH in critically ill patients. Intensive Care Med (1988) 1.95
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther (2004) 1.87
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther (2004) 1.62
Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut (1985) 1.60
Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab (2001) 1.58
Defecography: II. Contribution to the diagnosis of defecation disorders. Gastrointest Radiol (1984) 1.57
Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood (1998) 1.56
Evoked potentials investigation of visual dysfunction after methanol poisoning. Crit Care Med (1999) 1.55
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia (1997) 1.50
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol (1997) 1.49
Detection of anti-glomerular basement membrane antibodies by radioimmunological technique. Clinical application in human nephropathies. J Clin Invest (1974) 1.48
Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44
Rabies encephalitis mimicking the electrophysiological pattern of brain death. A case report. Eur Neurol (1993) 1.42
Methanol poisoning during late pregnancy. J Toxicol Clin Toxicol (1997) 1.41
Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood (1995) 1.39
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism. Scand J Gastroenterol (2002) 1.38
Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? Gut (1997) 1.38
Defecography: I. Description of a new procedure and results in normal patients. Gastrointest Radiol (1984) 1.38
Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem (1987) 1.36
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol (2000) 1.30
Detection of humoral and cell-mediated immunity to kidney basement membranes in human renal diseases. Am J Med (1972) 1.28
Tissue culture of normal rat glomeruli. Isolation and morphological characterization of two homogeneous cell lines. Invest Cell Pathol (1980) 1.27
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol (1999) 1.27
Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab (1999) 1.25
Evidence for mesangial glomerular receptors for angiotensin II linked to mesangial cell contractility. FEBS Lett (1980) 1.25
Alport's syndrome: experience at Hôpital Necker. Kidney Int Suppl (1982) 1.25
Encephalopathy with seizures after use of aluminium-containing bone cement. Lancet (1994) 1.20
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol (2001) 1.19
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol (2011) 1.09
Gastroduodenal motility in mechanically ventilated critically ill patients: a manometric study. Crit Care Med (1994) 1.07
Prostaglandin synthesis by mesangial and epithelial glomerular cultured cells. FEBS Lett (1979) 1.07
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol (2000) 1.06
Mercuric chloride induced autoimmune disease in Brown-Norway rats: sequential search for anti-basement membrane antibodies and circulating immune complexes. Eur J Clin Invest (1982) 1.06
Anti-alpha-galactosyl antibodies and immune complexes in children with Henoch-Schönlein purpura or IgA nephropathy. Kidney Int (1987) 1.05
Prevention of malignant exophthalmos after treatment of thyrotoxicosis. Lancet (1973) 1.04
Antiglomerular basement membrane nephritis after solvent exposure. Arch Intern Med (1980) 1.04
Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrinol (Copenh) (1986) 1.04
Comparison of weight- and height-based indices for assessing the risk of death in severely malnourished children. Am J Epidemiol (1996) 1.03
Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am J Gastroenterol (2002) 1.03
Chemical structure of tubular and glomerular basement membranes of human kidney. Isolation, purification, carbohydrate and amino acid composition. Eur J Biochem (1970) 1.02
Effect of renal insufficiency on the concentration of free retinol-binding protein in urine and serum. Clin Chim Acta (1988) 1.02
A model to standardise mortality of severely malnourished children using nutritional status on admission to therapeutic feeding centres. Eur J Clin Nutr (1997) 1.01
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00
Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy (1995) 0.98
Profile of soluble cytokine receptors in Crohn's disease. Gut (2005) 0.97
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol (1996) 0.96
Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man. Eur J Clin Invest (1972) 0.96
The influence of liver disease on the methylation of arsenite in humans. Arch Toxicol (1984) 0.96
Remission of Goodpasture's syndrome after withdrawal of an unusual toxic. Clin Nephrol (1985) 0.95
Experimental and human studies on antimony metabolism: their relevance for the biological monitoring of workers exposed to inorganic antimony. Br J Ind Med (1991) 0.95
CARD4/NOD1 is not involved in inflammatory bowel disease. Gut (2003) 0.94
Electron dense alteration of kidney basement membranes. A renal lesion specific of a systemic disease. Am J Med (1975) 0.93
Anti-laminin antibodies in workers exposed to mercury vapour. Toxicol Lett (1983) 0.93
Antibodies to laminin in preeclampsia. Kidney Int (1986) 0.93
In vivo studies on the mononuclear phagocyte system Fc receptor function in rheumatoid arthritis. Correlations with clinical and immunological variables. J Rheumatol (1985) 0.93
Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology (2000) 0.92
Assessment of chronic constipation: colon transit time versus defecography. Eur J Radiol (1999) 0.92
Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept (1998) 0.91
Possible role of human natural anti-Gal antibodies in the natural antitumor defense system. J Natl Cancer Inst (1989) 0.90
Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy? Acta Endocrinol (Copenh) (1987) 0.90
Chemical structure of tubular and glomerular basement membranes of human kidney. Isolation and characterization of the carbohydrate units. Eur J Biochem (1970) 0.90
[Solitary lesions of the rectum caused by suppositories combining acetylsalicylic acid and paracetamol]. Gastroenterol Clin Biol (1987) 0.89
Anti-tumor necrosis factor nonresponders in Crohn's disease: therapeutic strategies. Dig Dis (2009) 0.89
Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab (1993) 0.89
The metabolism of arsenic in humans acutely intoxicated by As2O3. Its significance for the duration of BAL therapy. Clin Toxicol (1981) 0.88
Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther (1995) 0.88
Pancreatic injury following acute methanol poisoning. J Toxicol Clin Toxicol (2000) 0.88
Clinical pattern of corticosteroid dependent Crohn's disease. Eur J Gastroenterol Hepatol (1998) 0.88
Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol (2001) 0.88
Anti-basement-membrane antibodies in the serum of healthy subjects. N Engl J Med (1986) 0.88
Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology (1989) 0.88
A convenient source of CFU-s inhibitors: the fetal calf liver. Cell Tissue Kinet (1984) 0.88
Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol (1986) 0.88
Human anti-alpha-galactosyl IgG reduces the lung colonization by murine MO4 cells. Invasion Metastasis (1987) 0.87
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology (1995) 0.86
Neurotoxicity to the basal ganglia shown by magnetic resonance imaging (MRI) following poisoning by methanol and other substances. J Toxicol Clin Toxicol (1997) 0.86